Cytochrome P450s and other enzymes in drug metabolism and toxicity
暂无分享,去创建一个
[1] D. Jollow,et al. Acetaminophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide. , 1990, Toxicology and applied pharmacology.
[2] J. Hedges,et al. Use of terfenadine and contraindicated drugs. , 1996, JAMA.
[3] F. Guengerich,et al. Microsomal oxidation of tribromoethylene and reactions of tribromoethylene oxide. , 2002, Chemical research in toxicology.
[4] Ortiz de Montellano,et al. Cytochrome P-450: Structure, Mechanism, and Biochemistry , 1986 .
[5] W. H. Schaefer,et al. Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone. , 2004, Toxicology and applied pharmacology.
[6] R. D. Stewart,et al. Experimental human exposure to trichloroethylene. , 1970, Archives of environmental health.
[7] H. Cui,et al. Liver-specific Deletion of the NADPH-Cytochrome P450 Reductase Gene , 2003, Journal of Biological Chemistry.
[8] Defeng Wu,et al. CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. , 2001, Free radical biology & medicine.
[9] F Peter Guengerich,et al. Function of human cytochrome P450s: characterization of the orphans. , 2005, Biochemical and biophysical research communications.
[10] C. Wolf,et al. Inactivation of the Hepatic Cytochrome P450 System by Conditional Deletion of Hepatic Cytochrome P450 Reductase* , 2003, The Journal of Biological Chemistry.
[11] Guengerich Fp,et al. Reaction of aflatoxin B1 exo-8,9-epoxide with DNA: kinetic analysis of covalent binding and DNA-induced hydrolysis. , 1997 .
[12] J. Fahey,et al. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Borzelleca. Paracelsus: herald of modern toxicology. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[14] P. Beaune,et al. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis. , 1990, The Journal of clinical investigation.
[15] B B Brodie,et al. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. , 1973, The Journal of pharmacology and experimental therapeutics.
[16] Y Chen,et al. Mechanism of the cardiotoxic actions of terfenadine. , 1993, JAMA.
[17] Kevin M Williams,et al. Reaction of aflatoxin B(1) oxidation products with lysine. , 2002, Chemical research in toxicology.
[18] J. Miller,et al. Historical perspectives on conjugation-dependent bioactivation of foreign compounds. , 1994, Advances in pharmacology.
[19] Ernesto Callegari,et al. A comprehensive listing of bioactivation pathways of organic functional groups. , 2005, Current drug metabolism.
[20] A. Y. Lu,et al. Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes. , 1976, The Journal of biological chemistry.
[21] J E Huff,et al. New evidence on the old problems of trichloroethylene. , 1971, IMS, Industrial medicine and surgery.
[22] S D Nelson,et al. The microsomal metabolism and site of covalent binding to protein of 3'-hydroxyacetanilide, a nonhepatotoxic positional isomer of acetaminophen. , 1984, Drug metabolism and disposition: the biological fate of chemicals.
[23] K. Kilburn. Is Neurotoxicity Associated with Environmental Trichloroethylene (TCE)? , 2002, Archives of environmental health.
[24] F. Guengerich,et al. Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases. , 2001, Chemical research in toxicology.
[25] A. Burlingame,et al. Identification of the Hepatic Protein Targets of Reactive Metabolites of Acetaminophen in Vivo in Mice Using Two-dimensional Gel Electrophoresis and Mass Spectrometry* , 1998, The Journal of Biological Chemistry.
[26] T. Baillie,et al. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. , 2004, Chemical research in toxicology.
[27] Huff Je,et al. New evidence on the old problems of trichloroethylene. , 1971 .
[28] A. Kalgutkar,et al. Minimising the potential for metabolic activation in drug discovery , 2005, Expert opinion on drug metabolism & toxicology.
[29] F. Guengerich,et al. Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[30] D. Thompson,et al. Role of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity , 2005, Critical reviews in toxicology.
[31] Daniel C. Liebler,et al. Elucidating mechanisms of drug-induced toxicity , 2005, Nature Reviews Drug Discovery.
[32] Barry C. Jones,et al. DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS , 2004, Drug Metabolism and Disposition.
[33] F. Guengerich,et al. Tetrachloroethylene oxide: hydrolytic products and reactions with phosphate and lysine. , 2002, Chemical research in toxicology.
[34] L. Wienkers,et al. Predicting in vivo drug interactions from in vitro drug discovery data , 2005, Nature Reviews Drug Discovery.
[35] F. Guengerich. Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. , 2003, Archives of biochemistry and biophysics.
[36] J. Uetrecht,et al. New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system. , 1999, Chemical research in toxicology.
[37] D. Russell,et al. Clinical importance of the cytochromes P450 , 2002, The Lancet.
[38] J. Miners,et al. “Phase I and Phase II” Drug Metabolism: Terminology that we Should Phase Out? , 2005, Drug metabolism reviews.
[39] PROFILES IN TOXICOLOGY , 2000 .
[40] R H Reitz,et al. In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models. , 1989, Toxicology and applied pharmacology.
[41] F. Guengerich,et al. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2. , 1998, Chemical research in toxicology.
[42] F Peter Guengerich,et al. Principles of covalent binding of reactive metabolites and examples of activation of bis-electrophiles by conjugation. , 2005, Archives of biochemistry and biophysics.
[43] B. Ames,et al. Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[44] F. Guengerich,et al. Human cytochrome P-450 enzymes. , 1992, Life sciences.
[45] F. Guengerich,et al. KINETICS AND MECHANISM OF HYDROLYSIS OF AFLATOXIN B1 EXO-8,9-EPOXIDE AND REARRANGEMENT OF THE DIHYDRODIOL , 1996 .
[46] B. Ames,et al. Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[47] P. van Bladeren,et al. Glutathione conjugate mediated toxicities. , 1990, Toxicology and applied pharmacology.
[48] F. Guengerich,et al. Reaction of trichloroethylene oxide with proteins and dna: instability of adducts and modulation of functions. , 2001, Chemical research in toxicology.
[49] T. Colby,et al. Progressive systemic sclerosis associated with exposure to trichloroethylene. , 1987, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[50] F. Guengerich,et al. Reaction of aflatoxin B1 exo-8,9-epoxide with DNA: kinetic analysis of covalent binding and DNA-induced hydrolysis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[51] F. Gonzalez,et al. Targeted Disruption of the Microsomal Epoxide Hydrolase Gene , 1999, The Journal of Biological Chemistry.
[52] F. Guengerich,et al. Activation of dihaloalkanes by thiol-dependent mechanisms. , 2003, Journal of biochemistry and molecular biology.
[53] Miller Re,et al. Oxidation of trichloroethylene by liver microsomal cytochrome P-450: evidence for chlorine migration in a transition state not involving trichloroethylene oxide. , 1982 .
[54] F. Guengerich,et al. Human cytochrome P-450 enzymes. , 1992, Life sciences.
[55] M. Williams-Johnson,et al. Toxicological profile for trichloroethylene , 1997 .
[56] J. Dorne,et al. Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[57] D. Kupfer,et al. Metabolic activation of pesticides with proestrogenic activity. , 1987, Federation proceedings.
[58] F. Guengerich,et al. Mechanism of Aqueous Decomposition of Trichloroethylene Oxide , 1999 .
[59] F Peter Guengerich,et al. Cytochrome P450: What Have We Learned and What Are the Future Issues? , 2004, Drug metabolism reviews.
[60] K Walton,et al. Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate? , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[61] Ulrich Klotz,et al. Inhibition of Terfenadine Metabolism , 1994, Clinical pharmacokinetics.